Type I interferon, interferon-a or -b, functions in cellular antiviral response via induction of genes called interferonstimulated genes (ISGs).1) One of the most prominent ISGs is ISG15 (interferon-stimulated gene 15 kDa), which is the first identified member of the family of ubiquitin-like proteins and contains two ubiquitin-like domains.2,3) Recently, ISG15 was found to function as an antiviral protein against Sindbis virus, human immunodeficiency virus (HIV)-1, influenza A and B viruses, herpes simplex virus type 1, and murine g-herpesvirus.4-6) ISG15 is conjugated to various cellular proteins (ISGylation) in a manner similar to ubiquitination that is catalyzed by the sequential action of E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin ligase) 7) : the E1 (UBE1L), E2 (UbcH8 and UbcH6), and E3 enzymes (Efp and Herc5) functioning in ISGylation have been identified. 2,3) Various target proteins modified with ISG15 have been identified, [8][9][10][11] but biological consequences of ISGylation have been studied in only a few cases: for example, ISGylation of the E2 ubiquitin-conjugating enzyme Ubc13 suppresses its enzyme activity.12,13) Ubc13 forms a heterodimer with ubiquitin-conjugating enzyme variant 1A (Uev1A)/ methyl methanesulfonate sensitivity 2 (Mms2) and this complex is involved in formation of the Lys63 (K63)-linked polyubiquitin chain linked to the target protein.14,15) In addition, a functional difference between the two Ubc13 complexes has been proposed.16) The fact that formation of the K63-linked polyubiquitin chain, catalyzed by the Ubc13-Uev1A complex, is necessary for activation of tumor necrosis factor receptor-associated factor 6 (TRAF6) and inhibitor of NF-kB (IkB)-kinase in the nuclear factor (NF)-kB pathway 17,18) led us to speculate that ISGylation of Ubc13 affects the NF-kB pathway. In this study, to determine the effect of ISGylation on the NF-kB pathway, we examined the effect of the ISGylation system on TRAF6/transforming growth factor b-activated kinase-1 (TAK1)-dependent NF-kB activation in HEK293 cells expressing TRAF6/TAK1. We found that expression of the ISGylation system suppresses NF-kB activation via TRAF6/TAK1 and reduces the level of polyubiquitinated TRAF6. Thus, we propose that ISGylation negatively controls the NF-kB pathway.
MATERIALS AND METHODSCell Culture and Transfection HEK293 cells were cultured in Dulbecco's modified Eagle's medium (Wako) supplemented with 10% heat-inactivated calf serum (Hyclone). Transfection was performed using Metafectene (Biontex) or Lipofectamine 2000 (Invitrogen).Plasmid Construction The open reading frames of human ISG15, UBE1L, UbcH8, Ubc13, Uev1A, TAK1, and mouse TRAF6 were amplified by polymerase chain reaction (PCR). 19,20) All constructs were verified by DNA sequencing. To generate the expression plasmids, the respective PCR fragments were subcloned into pCI-neo-6His, pCI-neoC3Flag, pCI-neo-3T7, pCI-neo-5HA, and pCI-neo-2S vectors that had been generated by inserting oligonucleotides encoding a hi...